Lithium Therapy and Phosphorus Management

Considerations in Special Populations

For patients who develop CKD while on lithium, phosphorus management becomes important as part of overall CKD care, with the National Kidney Foundation recommending target phosphorus ranges of 2.7-4.6 mg/dL in CKD Stages 3-4 and 3.5-5.5 mg/dL in CKD Stage 5 1

Before initiating lithium therapy, baseline laboratory assessment should include complete blood cell counts, thyroid function tests, urinalysis, blood urea nitrogen, creatinine, and serum calcium levels, as recommended by the American Academy of Child and Adolescent Psychiatry 2
Once a stable lithium dose is obtained, lithium levels, renal and thyroid function should be monitored regularly (every 3-6 months), according to the American Academy of Child and Adolescent Psychiatry 2
While specific monitoring of phosphorus levels is not routinely recommended for lithium therapy alone, it becomes important if the patient develops signs of renal impairment, as suggested by the National Kidney Foundation 1

Lithium remains a fundamental tool for the treatment of bipolar disorder, with therapeutic blood levels typically maintained between 0.2-0.6 mEq/L for maintenance therapy, as recommended by the American Academy of Family Physicians 3